36 related articles for article (PubMed ID: 38614876)
1. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Patel SP; Othus M; Chen Y; Wright GP; Yost KJ; Hyngstrom JR; Hu-Lieskovan S; Lao CD; Fecher LA; Truong TG; Eisenstein JL; Chandra S; Sosman JA; Kendra KL; Wu RC; Devoe CE; Deutsch GB; Hegde A; Khalil M; Mangla A; Reese AM; Ross MI; Poklepovic AS; Phan GQ; Onitilo AA; Yasar DG; Powers BC; Doolittle GC; In GK; Kokot N; Gibney GT; Atkins MB; Shaheen M; Warneke JA; Ikeguchi A; Najera JE; Chmielowski B; Crompton JG; Floyd JD; Hsueh E; Margolin KA; Chow WA; Grossmann KF; Dietrich E; Prieto VG; Lowe MC; Buchbinder EI; Kirkwood JM; Korde L; Moon J; Sharon E; Sondak VK; Ribas A
N Engl J Med; 2023 Mar; 388(9):813-823. PubMed ID: 36856617
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF
Long GV; Saw RPM; Lo S; Nieweg OE; Shannon KF; Gonzalez M; Guminski A; Lee JH; Lee H; Ferguson PM; Rawson RV; Wilmott JS; Thompson JF; Kefford RF; Ch'ng S; Stretch JR; Emmett L; Kapoor R; Rizos H; Spillane AJ; Scolyer RA; Menzies AM
Lancet Oncol; 2019 Jul; 20(7):961-971. PubMed ID: 31171444
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.
Najjar YG; McCurry D; Lin H; Lin Y; Zang Y; Davar D; Karunamurthy A; Drabick JJ; Neves RI; Butterfield LH; Ernstoff MS; Puzanov I; Skitzki JJ; Bordeaux J; Summit IB; Bender JO; Kim JY; Chen B; Sarikonda G; Pahuja A; Tsau J; Alfonso Z; Laing C; Pingpank JF; Holtzman MP; Sander C; Rose A; Zarour HM; Kirkwood JM; Tarhini AA
Clin Cancer Res; 2021 Aug; 27(15):4195-4204. PubMed ID: 33753453
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812].
Sharon CE; Tortorello GN; Ma KL; Huang AC; Xu X; Giles LR; McGettigan S; Kreider K; Schuchter LM; Mathew AJ; Amaravadi RK; Gimotty PA; Miura JT; Karakousis GC; Mitchell TC
Ann Oncol; 2024 Apr; ():. PubMed ID: 38614876
[No Abstract] [Full Text] [Related]
5. Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma.
Spagnolo F; Croce E; Boutros A; Tanda E; Cecchi F; Mascherini M; Solari N; Cafiero F; Queirolo P
Expert Rev Anticancer Ther; 2020 May; 20(5):403-413. PubMed ID: 32326767
[No Abstract] [Full Text] [Related]
6. Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.
Long GV; Menzies AM; Scolyer RA
J Clin Oncol; 2023 Jun; 41(17):3236-3248. PubMed ID: 37104746
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
[TBL] [Abstract][Full Text] [Related]
8. Educational Review: Neoadjuvant Approaches to Melanoma.
Sharon CE; Karakousis GC
Ann Surg Oncol; 2022 Dec; 29(13):8492-8500. PubMed ID: 35849287
[TBL] [Abstract][Full Text] [Related]
9. The Current State of Neoadjuvant Therapy in Resectable Advanced Stage Melanoma.
Bushara O; Tidwell J; Wester JR; Miura J
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444454
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant and Neoadjuvant Therapeutics for the Treatment of Cutaneous Melanoma.
Bruce WJ; Koljonen JL; Romanelli MR; Khan AU; Neumeister MW
Clin Plast Surg; 2021 Oct; 48(4):651-658. PubMed ID: 34503725
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
